» Articles » PMID: 17932126

Costs and Health Consequences of Chlamydia Management Strategies Among Pregnant Women in Sub-Saharan Africa

Overview
Date 2007 Oct 13
PMID 17932126
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Chlamydia is the most common bacterial sexually transmitted infection worldwide and a major cause of morbidity-particularly among women and neonates. We compared costs and health consequences of using point-of-care (POC) tests with current syndromic management among antenatal care attendees in sub-Saharan Africa. We also compared erythromycin with azithromycin treatment and universal with age-based chlamydia management.

Methods: A decision analytical model was developed to compare diagnostic and treatment strategies, using Botswana as a case. Model input was based upon (1) a study of pregnant women in Botswana, (2) literature reviews and (3) expert opinion. We expressed the study outcome in terms of costs (US$), cases cured, magnitude of overtreatment and successful partner treatment.

Results: Azithromycin was less costly and more effective than erythromycin. Compared with syndromic management, testing all attendees on their first visit with a 75% sensitive POC test increased the number of cases cured from 1500 to 3500 in a population of 100,000 women, at a cost of US$38 per additional case cured. This cost was lower in high-prevalence populations or if testing was restricted to teenagers. The specific POC tests provided the advantage of substantial reductions in overtreatment with antibiotics and improved partner management.

Conclusions: Using POC tests to diagnose chlamydia during antenatal care in sub-Saharan Africa entails greater health benefits than syndromic management does-and at acceptable costs-especially when restricted to younger women. Changes in diagnostic strategy and treatment regimens may improve people's health and even reduce healthcare budgets.

Citing Articles

Acceptability, feasibility and cost of point of care testing for sexually transmitted infections among South African adolescents where syndromic management is standard of care.

Marcus R, C P, Gill K, Smith P, Rouhani S, Mendelsohn A BMC Health Serv Res. 2023; 23(1):1078.

PMID: 37817160 PMC: 10566254. DOI: 10.1186/s12913-023-10068-8.


Associations between Awareness of Sexually Transmitted Infections (STIs) and Prevalence of STIs among Sub-Saharan African Men and Women.

Vasudeva M, Nakka R, Stock S, Ghebremichael M Trop Med Infect Dis. 2022; 7(8).

PMID: 35893654 PMC: 9332350. DOI: 10.3390/tropicalmed7080147.


Point-of-care testing and treatment of sexually transmitted and genital infections during pregnancy in Papua New Guinea (WANTAIM trial): protocol for an economic evaluation alongside a cluster-randomised trial.

Batura N, Saweri O, Vallely A, Pomat W, Homer C, Guy R BMJ Open. 2021; 11(8):e046308.

PMID: 34385236 PMC: 8362726. DOI: 10.1136/bmjopen-2020-046308.


Economic evaluation of point-of-care testing and treatment for sexually transmitted and genital infections in pregnancy in low- and middle-income countries: A systematic review.

Saweri O, Batura N, Adawiyah R, Causer L, Pomat W, Vallely A PLoS One. 2021; 16(6):e0253135.

PMID: 34138932 PMC: 8211269. DOI: 10.1371/journal.pone.0253135.


Diagnostic accuracy of the Xpert CT/NG and OSOM Trichomonas Rapid assays for point-of-care STI testing among young women in South Africa: a cross-sectional study.

Garrett N, Mitchev N, Osman F, Naidoo J, Dorward J, Singh R BMJ Open. 2019; 9(2):e026888.

PMID: 30782948 PMC: 6367982. DOI: 10.1136/bmjopen-2018-026888.


References
1.
Welte R, Postma M, Leidl R, Kretzschmar M . Costs and effects of chlamydial screening: dynamic versus static modeling. Sex Transm Dis. 2005; 32(8):474-83. DOI: 10.1097/01.olq.0000161181.48687.cf. View

2.
Cates Jr W . Contraception, unintended pregnancies, and sexually transmitted diseases: why isn't a simple solution possible?. Am J Epidemiol. 1996; 143(4):311-8. DOI: 10.1093/oxfordjournals.aje.a008744. View

3.
Peeling R, Holmes K, Mabey D, Ronald A . Rapid tests for sexually transmitted infections (STIs): the way forward. Sex Transm Infect. 2006; 82 Suppl 5:v1-6. PMC: 2563912. DOI: 10.1136/sti.2006.024265. View

4.
Vickerman P, Watts C, Peeling R, Mabey D, Alary M . Modelling the cost effectiveness of rapid point of care diagnostic tests for the control of HIV and other sexually transmitted infections among female sex workers. Sex Transm Infect. 2006; 82(5):403-12. PMC: 2563843. DOI: 10.1136/sti.2006.020107. View

5.
Romoren M, Rahman M, Sundby J, Hjortdahl P . Chlamydia and gonorrhoea in pregnancy: effectiveness of diagnosis and treatment in Botswana. Sex Transm Infect. 2004; 80(5):395-400. PMC: 1744896. DOI: 10.1136/sti.2003.007757. View